By: IPP Bureau
Last updated : July 15, 2026 4:54 pm
Omni-channel pharmacy chain accelerates expansion with plans to triple online order volume by March 2027
Zeelab Pharmacy has crossed 300 company-owned, company-operated (COCO) stores and surpassed 5,000 daily orders through its e-commerce platform, marking a significant milestone in the company's omni-channel expansion strategy.
The achievement underscores Zeelab's rapid growth as one of India's fastest-scaling pharmacy retail networks, driven by a technology-enabled "phygital" model that integrates company-owned retail outlets with digital healthcare services to improve access to affordable medicines.
The company reached the 300-store milestone while its online platform exceeded 5,000 daily orders within four years of launch, reflecting strong customer adoption across metropolitan centres as well as Tier II and Tier III cities.
Over the past six months, Zeelab has expanded its retail network by adding nearly 15 company-owned stores every month, with its strongest presence in Delhi-NCR, Uttar Pradesh, Maharashtra and West Bengal.
The company has set ambitious growth targets for March 2027, aiming to increase daily online orders to 15,000, offline orders to 35,000, and further expand its nationwide retail footprint.
Rohit Mukul, Founder and Chief Executive Officer of Zeelab Pharmacy, said, “Crossing 300 company-owned stores is more than a growth milestone; it reflects our conviction that quality healthcare can be made affordable at scale. India remains one of the world's largest pharmaceutical markets, yet out-of-pocket healthcare expenditure continues to place a significant burden on millions of families.”
“At Zeelab, we are addressing this gap by combining an integrated retail network, technology-led operations and a robust supply chain to make trusted, high-quality medicines accessible to more people. As we continue to expand, our ambition is to build India's most trusted affordable healthcare platform by setting new benchmarks in accessibility, affordability and customer experience," Mukul said.
Zeelab said its integrated omni-channel model has emerged as a key driver of growth, allowing customers to purchase medicines seamlessly through both physical stores and digital platforms.